Mitochondrial autophagy, or mitophagy, is a major mechanism involved in mitochondrial quality control via selectively removing damaged or unwanted mitochondria. Interactions between LC3 and mitophagy receptors such as FUNDC1, which harbors an LC3-interacting region (LIR), are essential for this selective process. However, how mitochondrial stresses are sensed to activate receptor-mediated mitophagy remains poorly defined. Here, we identify that the mitochondrially localized PGAM5 phosphatase interacts with and dephosphorylates FUNDC1 at serine 13 (Ser-13) upon hypoxia or carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP) treatment. Dephosphorylation of FUNDC1 catalyzed by PGAM5 enhances its interaction with LC3, which is abrogated following knockdown of PGAM5 or the introduction of a cell-permeable unphosphorylated peptide encompassing the Ser-13 and LIR of FUNDC1. We further observed that CK2 phosphorylates FUNDC1 to reverse the effect of PGAM5 in mitophagy activation. Our results reveal a mechanistic signaling pathway linking mitochondria-damaging signals to the dephosphorylation of FUNDC1 by PGAM5, which ultimately induces mitophagy.
INTRODUCTION
Mitochondria play a central role in the production of cellular ATP and metabolites required for normal cellular activities as well as in programmed cell death (both apoptosis and programmed necrosis) (Galluzzi et al., 2012; Wallace et al., 1998) . To fulfill such diverse and even opposing functions, mitochondrial quality must be tightly monitored to avoid harmful effects of mitochondria and to maintain the well-being of the cell (Chen and Chan, 2009; Youle and Narendra, 2011) . Mitophagy is recognized as one of the major mechanisms involved in mitochondrial quality control (Batlevi and La Spada, 2011) . Mitophagy is a complex process whereby damaged or unwanted mitochondria are selectively sorted and then removed, involving crosstalk between mitochondria and the autophagy machinery Lemasters, 2005; Youle and Narendra, 2011) . Mitochondria form a network in the cell and undergo constant fusion and fission, and the latter process may segregate damaged mitochondria from the network. When segregated mitochondria regain their membrane potential, they can fuse back into the mitochondrial network. Mitophagy is activated when mitochondria fail to restore their membrane potential to prevent detrimental effects (such as the release of cytochrome c) in the cell (Twig et al., 2008; Twig and Shirihai, 2011) . One such mechanism involves Parkin, an E3 ubiquitin ligase, and PTEN-induced putative protein kinase 1 (PINK1) (Narendra et al., 2008) . It has been suggested that when the mitochondrial potential is lost, PINK1 is stabilized Narendra et al., 2010) and is able to phosphorylate Parkin at serine 65 (Shiba-Fukushima et al., 2012) and to recruit Parkin onto the mitochondria, where it ubiquitinates a number of mitochondrial membrane proteins, leading to the recruitment of p62 (Geisler et al., 2010) and ULK1 (Mizushima, 2010) to carry out mitophagy. Defects in mitophagy can lead to the accumulation of dysfunctional mitochondria, which is a characteristic of aging-related diseases (Chan, 2006; DiMauro and Schon, 2008; Palikaras and Tavernarakis, 2012 ) (such as heart failure, Alzheimer disease, and Parkinson disease) and cancers . Thus, deciphering the regulatory mechanism of mitophagy holds promise for fighting these currently incurable diseases.
Several mitophagy receptors have been reported to mediate mitophagy thus far, including ATG32 in yeast (Kanki et al., 2009; Okamoto et al., 2009) , NIX/BNIP3L (Novak et al., 2010; Sandoval et al., 2008) for red blood cell maturation, and BNIP3 (Hanna et al., 2012) for the selective removal of endoplasmic reticulum and mitochondria under conditions of hypoxia. We recently identified FUNDC1 as a specific receptor involved in mitophagy in mammalian cells . These proteins A) HeLa cells were exposed to 1% O 2 (left) or treated with 10 mM FCCP (right) or Earle's balanced salt solution (EBSS) for the indicated times, and then FCCP was washed and the cells were cultured in fresh medium for 2 or 4 hr (FCCP 6h + Withdrawal). The phosphorylation of FUNDC1 at Ser-13 was analyzed using a phosphospecific antibody against . The levels of other mitochondrial marker proteins and LC3-I/II were detected via western blotting. Grayscale values of the p-Ser13 and FUNDC1 bands measured with ImageJ software are shown under the corresponding bands to indicate the band intensities. The ratios of the band intensity of p-Ser13 to FUNDC1 (p-Ser13/FUNDC1) are shown on top of the bands, indicating that dephosphorylation of FUNDC1 at Ser-13 took place under mitophagic stresses (hypoxia or FCCP treatment).
(legend continued on next page) Molecular Cell PGAM5 and CK2 Control FUNDC1-Mediated Mitophagy possess a classical LC3-interacting region (LIR) that interacts with ATG8 or LC3 to recruit isolation membranes for subsequent mitophagy. It has also been suggested that the NIX and mTOR pathways are required for Parkin-mediated mitophagy (Ding et al., 2010; Gilkerson et al., 2012) . It is therefore becoming evident that in response to nutritional and energy requirements and mitochondrial stress, distinct mechanisms exist for selective mitophagy that are crucial for the cell to maintain proper mitochondrial homeostasis.
A critical issue is how this receptor-mediated mitophagy is regulated in physiological and pathophysiological settings. In particular, what are the sensors that activate receptor-mediated mitophagy in response to mitochondrial stresses (Novak, 2012) ? Recently, posttranslational modifications such as protein phosphorylation were found to regulate mitophagic processes (Egan et al., 2011; Mao et al., 2011) . ATG32 is phosphorylated in response to oxidative stress, which promotes its interaction with ATG11 and ATG8 (Aoki et al., 2011; Farré et al., 2013) . Additionally, phosphorylation of serine residues 17 and 24 of BNIP3 promotes its binding to LC3B and GATE-16 (Zhu et al., 2013) . We previously found that phosphorylation of FUNDC1 prevented the interaction between the LIR of FUNDC1 and LC3 in a mammalian system. Thus, phosphorylation of mitophagic receptors plays a critical role in either promoting or inhibiting mitophagy in a context-dependent manner. In this study, we identified that the mitochondrial phosphoglycerate mutase PGAM5, a serine/threonine (Ser/Thr) phosphatase located at mitochondria (Takeda et al., 2009) , is responsible for the dephosphorylation of FUNDC1 at serine 13 (Ser-13) in response to depolarization of mitochondrial membrane potential or hypoxia. On the other hand, CK2 (casein kinase 2), a constitutive Ser/Thr kinase, phosphorylates FUNDC1 at Ser-13 under normal conditions. Our results therefore suggest that PGAM5 and CK2 regulate the reversible phosphorylation of FUNDC1 associated with receptor-mediated mitophagy.
RESULTS

FUNDC1
Dephosphorylation at Ser-13 Is Associated with the Activation of Mitophagy To understand the regulatory mechanism underlying FUNDC1-mediated mitophagy, we performed mass spectrometric analysis and found that both tyrosine 18 (Tyr-18) and Ser-13 of FUNDC1 were phosphorylated. We have previously shown that the phosphorylation of Tyr-18 by Src kinase is critical for hypoxia-induced mitophagy . We therefore focused on the molecular details of the regulation of mitophagy via the phosphorylation of Ser-13 in response to mitochondrial stress. We first generated a phosphospecific antibody against FUNDC1 phosphorylated at Ser-13. Calf intestine alkaline phosphatase treatment and mutational analysis confirmed that this antibody is highly specific (Figure S1A available online). Similar to dephosphorylation at Tyr-18, hypoxia induced a significant dephosphorylation of FUNDC1 at Ser-13, accompanied by degradation of mitochondrial proteins and an increase of LC3-II ( Figure 1A , left panel). Interestingly, carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP), a widely used uncoupler of the mitochondrial membrane potential (Bakker et al., 1974) and inducer of mitophagy (Ding et al., 2010; Narendra et al., 2008) ( Figure 1A , right panel; and Figure S1B ), also induced the dephosphorylation of Ser-13 of FUNDC1 ( Figure 1A , right panel). Dephosphorylation occurs prior to the reduction of FUNDC1 and other mitochondrial marker proteins, such as TOM20 (an outer membrane protein) and TIM23 (an inner membrane protein), due to mitophagy ( Figure 1A , right panel). These changes were accompanied by the appearance of LC3-II ( Figure 1A ), which is a biochemical hallmark of general autophagy (Kabeya et al., 2000; Kuma et al., 2007) . This dephosphorylation is reversible, because washout of FCCP, which recovers the mitochondrial membrane potential and mitochondrial network (Geisler et al., 2010) , also restored the phosphorylation of FUNDC1 at Ser-13, accompanied by a reduction of LC3-II levels and the recovery of mitochondrial marker proteins ( Figure 1A , right panel). Electron microscopy analysis revealed that FCCP alone indeed induced typical autophagosomes enclosing mitochondria in HeLa cells ( Figure 1B ). In contrast, starvation (via Earle's balanced salt solution treatment), which is a general autophagy inducer, did not induce FUNDC1 dephosphorylation at Ser-13 ( Figure 1A , right panel; Figures S1C and S1D) , showing that FUNDC1 dephosphorylation may be specific to mitochondrial stresses. To ascertain whether FUNDC1 is indeed involved in FCCP-induced mitophagy, we specifically knocked down FUNDC1 via small hairpin RNA (shRNA) and found that the degradation of mitochondrial proteins (such as TOM20 and TIM23) was attenuated upon treatment with FCCP ( Figure 1C ). Bafilomycin A1 (BA1) enhanced the levels of LC3-II and prevented the degradation of mitochondrial proteins ( Figure 1C ), indicating that FUNDC1 is involved in increasing the FCCPinduced mitophagic flux (Klionsky et al., 2008 (Klionsky et al., , 2012 ). To further demonstrate that dephosphorylation of Ser-13 promotes mitophagy, we introduced mutations resulting in the substitution of Ser-13 to Ala (S13A) or Tyr-18 to Ala (Y18A) (which impairs LIR and mitophagic activity) in FUNDC1 and expressed these (B) HeLa cells were treated with or without FCCP for 2 hr and then the samples were analyzed by electron microscopy. Arrows indicate that mitochondria are enclosed within autophagosomes. (C) Scramble or FUNDC1 knockdown (KD) HeLa cells were treated with 10 mM FCCP for 6 hr in the presence or absence of bafilomycin A1 (BA1), and the levels of LC3 and mitochondrial proteins (TOM20, TIM23) were analyzed via western blotting. (D) FUNDC1 knockdown cells were transfected with wild-type FUNDC1-Myc or the indicated mutants and GFP-LC3 plasmids for 24 hr. The cells were then fixed and immunostained with Myc (red) and TOM20 (purple). Scale bar, 10 mm. (E) The GFP-LC3 aggregates present in cells treated as in (D) were quantified using ImageJ (mean ± SEM; n = 100 cells from three independent experiments; *p < 0.05). (F) FUNDC1 knockdown cells were transfected with FUNDC1-Myc or the indicated mutants for 24 hr. BA1 was added 4 hr before harvesting, and the cell lysates were subjected to western blotting. See also Figure S1 . Figure S1E ). Compared to wild-type FUNDC1, the S13A mutant showed more pronounced mitophagy, as shown by the appearance of LC3 aggregates surrounding mitochondria ( Figures 1D and 1E ) and via western blotting to detect LC3-II and mitochondrial protein levels ( Figure 1F ). Western blotting analysis also revealed that BA1 was able to enhance LC3-II levels and block mitochondrial protein degradation, indicating that the S13A mutant shows a greater ability to increase the autophagic flux compared to wild-type FUNDC1 ( Figure 1F ). Consistent with our previous findings, mutation of Tyr-18 to Ala (Y18A) in the LIR abolished mitophagic activity (Figures 1D-1F) . Collectively, these results demonstrated that FUNDC1 dephosphorylation at Ser-13 is strongly associated with the activation of mitophagy.
Dephosphorylation of FUNDC1 at Ser-13 Enhances the Interaction between FUNDC1 and LC3
We reasoned that dephosphorylation of Ser-13 could also enhance the interaction between FUNDC1 and LC3 and thus the activation of mitophagy. To test this hypothesis, we used glutathione S-transferase (GST)-LC3 or antibody against endogenous LC3 to precipitate wild-type and S13A mutant FUNDC1, and the results revealed that S13A mutant indeed showed a higher binding affinity than wild-type FUNDC1 (Figures 2A and 2B) , which normally is phosphorylated in cells. Consistent with the above finding that FCCP induced FUNDC1 dephosphorylation, GST-LC3 precipitated more endogenous FUNDC1 when HeLa cells were treated with FCCP ( Figure 2C ). To further verify that the dephosphorylation of Ser-13 affects the interaction between FUNDC1 and LC3, we performed isothermal titration calorimetric (ITC) experiments using LC3 and synthetic FUNDC1 peptides (9th-25th amino acid residues, encompassing Ser-13 and the LIR) either phosphorylated at Ser-13 (p-F-pep) or not (F-pep) . The ITC analysis clearly revealed that the unphosphorylated FUNDC1 peptide exhibited a higher binding affinity compared to the phosphorylated peptide ( Figure 2D ). The dissociation constant (K D ) increased over 5-fold, from 5.8 mM for the unphosphorylated form (F-pep) to 30.1 mM for the phosphorylated form (p-F-pep) ( Figure 2D ). Because the unphosphorylated FUNDC1 peptide exhibits a higher affinity for LC3 compared to the phosphorylated peptide, it was reasonable to speculate that the unphosphorylated FUNDC1 peptide might competitively block the interaction between endogenous FUNDC1 and LC3 to a greater extent than the phosphorylated form. Indeed, a GST pull-down assay revealed that the unphosphorylated peptide could effectively block the interaction between endogenous FUNDC1 and exogenous LC3, while the phosphorylated peptide showed less activity ( Figure 2E ). To further demonstrate that the phosphorylation status of FUNDC1 at Ser-13 is of functional importance for mitophagy, we synthesized cell-permeable peptides composed of the HIV-1 Tat protein transduction domain attached to either the unphosphorylated peptide (Tat-F-pep) or the peptide phosphorylated at Ser-13 (Tat-p-F-pep) derived from the 9th to 25th amino acids of FUNDC1. Interestingly, FCCP-induced mitochondrial protein degradation was significantly inhibited when cells were pretreated with the unphosphorylated peptide in a dose-dependent manner ( Figure 2F ). However, the phosphorylated cell-permeable peptide, which exhibits a lower capacity to interact with endogenous LC3, displayed a minimal ability to inhibit mitochondrial protein degradation induced by FCCP and hypoxia (Figures 2F-2H; Figure S2 ), although general autophagy was not affected, as reflected by the appearance of LC3-II. Taken together, our findings demonstrated that dephosphorylation of FUNDC1 at Ser-13 positively regulates mitophagy through enhancing the interaction between FUNDC1 and LC3.
PGAM5 Is a Phosphatase for FUNDC1
To understand the mechanism underlying the dephosphorylation of FUNDC1 and the activation of mitophagy, we next sought to identify which phosphatase is responsible for the dephosphorylation of FUNDC1 at Ser-13. We screened a number of phosphatases linked to hypoxic or other stress responses and examined their capacity to reduce the phosphorylation of FUNDC1 using a phosphospecific FUNDC1 Ser-13 antibody as well as to promote FUNDC1-mediated mitophagy when expressed in HeLa cells. One of these phosphatases was PGAM5, which was found to dramatically increase the dephosphorylation of FUNDC1 at Ser-13 ( Figures S3A-S3C ). PGAM5 is a mitochondrial-localized Ser/Thr phosphatase that displays two alternative splicing isoforms: a long form (PGAM5L) and a short form (PGAM5S). (C) HeLa cells were treated with FCCP for the indicated times, and cell numbers were adjusted to obtain equivalent FUNDC1 levels. A GST pull-down assay was performed using GST-LC3 proteins incubated with cell lysates treated as described above. The coprecipitated complexes were subjected to western blotting. (D) ITC titration of LC3B with FUNDC1 peptides encompassing the LIR motif (9th-25th residues), including F-pep (unphosphorylated peptide, QDYESDDDSYEVLDLTE) and p-F-pep (peptide phosphorylated at Ser-13, QDYEpSDDDSYEVLDLTE). The upper panel shows the raw ITC data, and the lower panel shows the integrated heat per titration step (points) and best-fit curves. The dissociation constant (K D ) of p-F-pep showed an over 5-fold increase compared to that of F-pep, indicating a weakened affinity for LC3B. K A , association constant; DH, change in enthalpy; DS, change in entropy. (E) GST-LC3 proteins were incubated with HeLa cell lysates, and F-pep or p-F-pep was added to a final concentration of 250 nM. A GST pull-down assay was performed, and the coprecipitated FUNDC1 protein level was analyzed using western blotting. (F) HeLa cells were pretreated with a cell-permeable peptide composed of the HIV-1 Tat protein transduction domain (PTD) attached to the 9th-25th amino acids of FUNDC1 (Tat-F-pep, GRKKRRQRRRPQDYESDDDSYEVLDLTEY) for 1 hr at the indicated concentrations, and 10 mM FCCP was then added, followed by incubation for an additional 6 hr. The cells were finally lysed and subjected to western blotting. (G) HeLa cells were pretreated with 250 nM Tat-F-pep or the corresponding peptide phosphorylated at Ser-13 of FUNDC1 (Tat-p-F-pep, GRKKRRQRRRPQDYEpSDDDSYEVLDLTEY, 9th-25th amino acids of FUNDC1, phosphorylated at Ser-13) for 1 hr, and 10 mM FCCP was then added, followed by incubation for an additional 6 hr. The cells were lysed and subjected to western blotting analysis. (H) The intensity of TOM20 and TIM23 of western blotting bands in Figure 2G was measured with ImageJ software. Data are the mean value of three experiments. See also Figure S2 . (A) HeLa cells transfected with plasmids harboring the PGAM5 long isoform (PGAM5L) or short isoform (PGAM5S) were lysed, followed by centrifugation. The supernatants were subsequently collected, and the pellets were further dissolved with 1% SDS. These lysates were subjected to western blotting, and the phosphorylation status of Ser-13 of FUNDC1 was analyzed. The protein contents of the pellets in SDS were determined with anti-Lamin A and anti-histone H2A antibodies. (B) HeLa cells transfected with plasmids containing PGAM5L or the phosphatase-dead mutant (H105A) were harvested, and the obtained lysates were then subjected to western blotting analysis. (C and D) HeLa cell lysates were subjected to immunoprecipitation (IP) with an anti-FUNDC1 antibody (C) or anti-PGAM5 antibody (D) . PGAM5 and FUNDC1 were detected in the immune complexes via western blotting using an anti-PGAM5 or anti-FUNDC1 antibody, respectively. (E) HeLa cells transfected with Myc-tagged PGAM5 and Flag-tagged FUNDC1 were treated with or without 10 mM FCCP for 2 hr, and IP was performed with an anti-Flag antibody. Co-IP PGAM5 was detected through western blotting using an anti-Myc antibody.
(legend continued on next page)
PGAM5S is more hydrophobic than PGAM5L and does not dissolve in mild detergent but does dissolve in 1% SDS . When ectopically expressed in HeLa cells under identical conditions, PGAM5L showed a greater activity to dephosphorylate FUNDC1 at Ser-13 compared to PGAM5S (Figure 3A) . In contrast, a phosphatase-dead mutant of PGAM5 (H105A) (Takeda et al., 2009) failed to induce the dephosphorylation of FUNDC1 ( Figure 3B ). These results indicate that PGAM5L may be the major phosphatase responsible for the dephosphorylation of FUNDC1. We next asked whether FUNDC1 could interact with PGAM5L to promote mitophagy, and the results showed that ectopically expressed PGAM5 was able to immunoprecipitate (IP) FUNDC1 ( Figure S3D ). Indeed, reciprocal IP revealed that endogenous PGAM5 interacts with endogenous FUNDC1 (Figures 3C and  3D ; Figures S3E and S3F ). More importantly, under FCCP conditions, which induce FUNDC1 dephosphorylation and higher affinity to LC3 (Figure 3G ), the interaction between FUNDC1 and PGAM5L was also significantly enhanced (Figures 3E-3G ; Figure S3G ), and crosslinking analysis further supports this conclusion ( Figure 3H ). It was interesting to note that FUNDC1 seemed to preferentially interact with LC3-I, suggesting a possible role of their interaction for mitochondrial homeostasis ( Figure 3G ; Figure S4A ). To further verify that FUNDC1 is a direct substrate of PGAM5, we incubated purified wild-type recombinant PGAM5L and the phosphatase-dead (H105A) mutant protein with FUNDC1-Myc protein precipitated from 293T cells (in which FUNDC1 is normally maintained in its phosphorylated form) using an anti-Myc antibody . As shown in Figure 3I , only wild-type PGAM5L significantly dephosphorylated FUNDC1 at Ser-13, whereas the phosphatase-dead mutant of PGAM5L failed to do so. To further verify the critical role of PGAM5 in FUNDC1 dephosphorylation, we performed small interfering RNA (siRNA) knockdown of PGAM5 expression using three independent siRNA oligos targeting PGAM5. Compared to scramble siRNA, knockdown of PGAM5 significantly inhibited FCCP-induced FUNDC1 Ser-13 dephosphorylation ( Figure 3J ). These results demonstrate that PGAM5L can interact with FUNDC1 and dephosphorylate FUNDC1 at Ser-13.
Knockdown of PGAM5 Suppresses Stress-Induced Mitophagy
We next determined that PGAM5-mediated dephosphorylation FUNDC1 at Ser-13 is of functional importance for the activation of mitophagy. In contrast to treatment with scramble siRNA, knockdown of PGAM5, which blocked FUNDC1 dephosphorylation, attenuated the mitochondrial protein degradation induced by FCCP (Figures 4A and 4B) . A rescue experiment showed that wild-type PGAM5, but not the phosphatase-dead mutant H105A, could restore the mitochondria degradation and FUNDC1 dephosphorylation in PGAM5 knockdown cells (Figure 4C) . Accordingly, the interaction between FUNDC1 and LC3 promoted by FCCP could be attenuated by PGAM5 knockdown ( Figures 4D and 4E) . Interestingly, as shown in Figures 4F  and 4G , in the presence of FCCP, the number of GFP-LC3 aggregates was significantly reduced when PGAM5 was knocked down, suggesting that this autophagic phenotype is due to mitochondrial stress. To confirm that the role of PGAM5 in mitophagy is mediated through the dephosphorylation of FUNDC1 at Ser-13, a rescue experiment was performed in which wild-type FUNDC1 and the S13A mutant (which is insensitive to PGAM5 dephosphorylation but retains LIR and mitophagic activity) were transfected into PGAM5 knockdown cells. As expected, the S13A mutant, but not wild-type FUNDC1, restored the reduced levels of TIM23 and TOM20 in PGAM5 knockdown cells treated with FCCP ( Figure 4H ). We next examined whether PGAM5 also affects hypoxia-induced mitophagy, and it was indeed found that knockdown of PGAM5 prevented the dephosphorylation of FUNDC1 at Ser-13 and mitochondrial protein degradation under hypoxic conditions, although LC3-II formation was not blocked ( Figure 4I ). Consistent with previous data, ectopically expressing wild-type PGAM5, but not H105A, can rescue the mitochondrial degradation and dephosphorylation of FUNDC1 in PGAM5 knockdown cells ( Figure S4C ). These results demonstrated that PGAM5 specifically activates mitochondrial autophagy through the dephosphorylation of FUNDC1 at Ser-13.
CK2 Is Responsible for Ser-13 Phosphorylation
Because the dephosphorylation of Ser-13 of FUNDC1 is reversible when FCCP is washed out (Figure 1A) , we next examined which protein kinase is responsible for the phosphorylation of FUNDC1. A sequence alignment performed for FUNDC1 predicted that Ser-13 is highly conserved and is surrounded by acidic amino acids, which is a signature motif for CK2 (Meggio et al., 1994; Pinna, 2002; Rekha and Srinivasan, 2003) (Figure 5A ). To test whether CK2 is indeed the kinase responsible for the phosphorylation of Ser-13, we first treated HeLa cells with the typical CK2 inhibitor TBBt (Zien et al., 2005) and (F) HeLa cells were treated with 10 mM FCCP for 2 hr, and then IP was performed with an anti-PGAM5 antibody; co-IP endogenous FUNDC1 was detected by western blotting. (G) HeLa cells were treated with 10 mM FCCP for 2 hr or 6 hr. IP was performed with an anti-FUNDC1 antibody. Co-IP endogenous PGAM5 and LC3 were detected by western blotting. (H) HeLa cells were treated with 10 mM FCCP for 2 hr or 6 hr. The cells were then collected and subjected to crosslinking reaction with 1 mM thiol-cleavable crosslinker, DSP (dithiobis[succinimidylpropionate]), for 2 hr. The cells were then lysed and IP was performed with an anti-FUNDC1 antibody. Co-IP PGAM5 and LC3 were detected by western blotting. 
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PGAM5 and CK2 Control FUNDC1-Mediated Mitophagy observed a decreased FUNDC1 phosphorylation level at Ser-13 ( Figure 5B ). CK2 is a family of protein kinases that are mainly composed of two catalytic subunits, CK2a1 and CK2a2, and one regulatory subunit, CK2b, in humans. An in vitro kinase assay showed that either one of the CK2 catalytic subunits (a1 or a2), but not the kinase-dead mutants (CK2a1K68M and CK2a2K69M) (Cavin et al., 2003) , is able to phosphorylate FUNDC1 ( Figures 5C and 5D ). As shown in Figure 5E , an in vitro reconstitution experiments showed that the FUNDC1 phosphorylation by CK2 can be removed by wild-type PGAM5, but not phosphatase-dead mutant H105A. To further ascertain whether CK2 is able to phosphorylate FUNDC1 under physiological conditions, we performed an immunodepletion analysis of CK2 subunits. In HeLa cell lysates, each endogenous CK2 subunit was depleted either individually or in combination with the other subunits via IP with antibodies targeting the CK2 subunits. The immunodepleted lysates (playing as the role of kinases) were then incubated with GST-FUNDC1 or the mutant form of the protein in an in vitro kinase assay, as described above. We found that depletion of either of the endogenous CK2 subunits in HeLa cell lysates resulted in a slightly decreased ability to phosphorylate FUNDC1 compared to the immunoglobulin G control or nontreated lysate ( Figures 5F and 5G) . Furthermore, immunodepletion of both catalytic subunits (a1 and a2) abolished the ability to phosphorylate FUNDC1. These data showed that CK2 is responsible for the phosphorylation of FUNDC1 at the Ser-13 residue.
CK2 Inhibits PGAM5/FUNDC1-Mediated Mitophagy
Because the reversible phosphorylation of FUNDC1 determines mitophagy activity, we next explored the functional significance of CK2 in PGAM5/FUNDC1-mediated mitophagy. We found that knockdown of either of the CK2 catalytic subunits, but not the regulatory subunit, significantly decreased the level of Ser-13 phosphorylation compared to scramble cells ( Figure 5H) . A GST pull-down assay showed that GST-LC3 precipitated more endogenous FUNDC1 from stable CK2a1 knockdown or CK2a2 knockdown cells compared to scramble cells, as expected ( Figure 6A ). Consistent with this, the interaction between endogenous FUNDC1 and LC3 is also increased in CK2a1 knockdown cells ( Figure S4A ). More importantly, knockdown of CK2 promoted the dephosphorylation of FUNDC1 and mitophagy compared to scramble cells upon FCCP treatment (Figure 6B) . Additionally, we ectopically expressed FUNDC1-Myc or S13A mutant in stable CK2a1 knockdown or scramble cells and found that the presence of S13A resulted in a greater number of GFP-LC3 aggregates compared to wild-type FUNDC1 in the scramble-treated cells ( Figures 6C and 6D) . Interestingly, CK2a1 knockdown cells expressing wild-type FUNDC1 showed more GFP-LC3 aggregates than the corresponding scramble cells, possibly due to decreased Ser-13 phosphorylation in CK2a1 knockdown cells ( Figures 6C and 6D ). On the other hand, mitophagy caused by the S13A mutant, which could not be phosphorylated, was not further increased in CK2a1 knockdown cells compared to scramble cells ( Figures 6C and 6D ). This suggests that the pronounced mitophagy induced in CK2a1 knockdown cells by wild-type FUNDC1 is dependent on Ser-13 phosphorylation. Strikingly, we found that both FCCP and hypoxia promote the interaction between FUNDC1 and PGAM5 ( Figure 6E ; Figure S4B ), whereas these stresses promote the dissociation of CK2a1, CK2a2, and Src kinase (Figure 6E ; Figure S4B ). These results further reinforce our hypothesis that the reversible phosphorylation of FUNDC1 at Ser-13 by PGAM5 and CK2 dictates the interaction between FUNDC1 and LC3 associated with mitophagy. Figure 3J , and western blotting was performed to detect mitochondrial protein levels. (B) The intensity of TOM20 and TIM23 bands in (A) was measured with ImageJ software. Data are the mean value of three experiments. (C) HeLa cells were transfected with scramble or PGAM5 siRNA oligos for 48 hr, and the cells were then transfected with empty vector or a plasmid containing Myc-PGAM5 or the H105A mutant, as indicated, for 24 hr before treatments with FCCP for 6 hr. Western blotting was performed to detect mitochondrial protein levels. (D) HeLa cells were transfected with siRNA oligos specifically targeting PGAM5 mRNA or scramble siRNA oligos for 72 hr, after which the cells were treated with 10 mM FCCP for 2 hr. Cell numbers were adjusted to obtain equivalent levels of FUNDC1. A GST pull-down assay was performed using GST-LC3 proteins, as described above. The coprecipitated complexes were subjected to western blotting. (E) HeLa cells were transfected with siRNA oligos specifically targeting PGAM5 mRNA or scramble siRNA oligos for 72 hr, and the cells were then treated with FCCP (10 mM) for 2 hr. IP was performed with an anti-FUNDC1 antibody. Co-IP endogenous LC3 was detected through western blotting. (F) HeLa cells were transfected with siRNA oligos specifically targeting PGAM5 mRNA or scramble siRNA oligos. At 48 hr after transfection, the cells were transfected with the GFP-LC3 plasmid for 24 hr and then treated with 10 mM FCCP for 2 or 6 hr. Mitochondria were immunostained with an anti-TOM20 antibody.
(G) HeLa cells were treated as in (F) , and GFP-LC3 aggregates were quantified using ImageJ (mean ± SEM; n = 100 cells from three independent experiments, **p < 0.01).
(H) HeLa cells were transfected with siRNA oligos specifically targeting PGAM5 mRNA or scramble siRNA oligos for 48 hr, after which the cells were transfected with empty vector or a plasmid containing FUNDC1-Myc or the S13A mutant, as indicated, for 24 hr and then treated with FCCP for 6 hr. Western blotting was performed to detect mitochondrial protein levels. (I) HeLa cells were transfected with siRNA oligos specifically targeting two different regions of PGAM5 mRNA (1# and 2#). At 48 hr after transfection, a subset of the cells was exposed to 1% O 2 for 24 hr. Western blotting was performed to detect the levels of mitochondrial proteins and LC3. Sc, scramble siRNA oligos. See also Figures S4A and S4C . (A) Alignment of FUNDC1 sequences from multiple species revealed that Ser-13 is highly conserved and is surrounded by acidic amino acids, which is a signature motif recognized by CK2. X is any residue except basic residues, and X 0 is any residue except basic or proline residues.
(B) HeLa cells were treated with the CK2 inhibitor TBBt for 2 or 6 hr. The cells were then lysed and subjected to western blotting.
(legend continued on next page)
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PGAM5 and CK2 Control FUNDC1-Mediated Mitophagy to hypoxia or FCCP treatments, dephosphorylation of both Tyr-18 and Ser-13 occurs in a similar fashion ( Figure 7A ). This is consistent with the data showing the dissociation of CK2 and Src kinase and enhanced interaction of FUNDC1 with PGAM5 ( Figure 6E ). It is possible that dephosphorylation at both sites are required for the activation of mitophagy. To test this, we first treated HeLa cells with CK2 inhibitor (TBBt) or Src inhibitors (PP2 and SU666) and found that these inhibitors effectively induced dephosphorylation at Ser-13 or Tyr-18 of FUNDC1, respectively ( Figure 7B ). Interestingly, only the combination of these two types of inhibitors, but not these inhibitors alone, leads to mitochondrial protein degradation and autophagosomes enclosing mitochondria ( Figure 7B ; Figure S5 ). This is highly specific, because the protein level of endoplasmic reticulum marker protein Calnexin remains intact ( Figure 7B ). The mitochondrial protein degradation was strongly inhibited by autophagy inhibitor BA1 ( Figure 7C ) and by knockdown of FUNDC1 ( Figure 7D ), reinforcing our notion that the combination of these inhibitors induced FUNDC1-dependent mitophagy. To further support this, we showed that when CK2a1 was knocked down, Src kinase inhibitor alone is then sufficient to induce the mitochondrial protein degradation ( Figure 7E ). We thus conclude that although the phosphorylation of two sites may be regulated by distinct mechanisms, they functionally cooperate to regulate mitophagy.
DISCUSSION
Having identified FUNDC1 as a mitophagy receptor in a mammalian system, we further addressed the critical mechanism underlying the sensing of mitochondrial stresses to activate receptor-mediated mitophagy. We showed that PGAM5, a Ser/ Thr phosphatase located at mitochondria (Takeda et al., 2009) , is able to dephosphorylate FUNDC1 at Ser-13. Under normal (unstressed) conditions, FUNDC1 is phosphorylated at Ser-13 by CK2 and at Tyr-18 by Src kinase to inhibit its interaction with LC3 for subsequent mitophagy. Upon loss of the mitochondrial membrane potential or under hypoxic conditions, PGAM5 exhibits a pronounced interaction with FUNDC1, while CK2 and Src kinase dissociate from it, thus leading to the dephosphorylation of FUNDC1 and, hence, the activation of receptor-mediated mitophagy. Our results demonstrated that reversible phosphorylation of the mitophagy receptor FUNDC1 plays a role in fine-tuning mitophagy activity in response to mitochondrial stresses ( Figure 7F ). The mitochondrial membrane potential is the driving force for mitochondrial ATP synthesis (Mitchell and Moyle, 1968) and mitochondrial protein import (Schleyer et al., 1982) involving CK2 (Schmidt et al., 2011) . Loss of the membrane potential is indicative of impaired mitochondrial function and is a prerequisite for mitophagy (Kim and Lemasters, 2011; Twig and Shirihai, 2011) . Previous work has elegantly shown that loss of the mitochondrial membrane potential can lead to the stabilization of PINK1, which may phosphorylate and recruit Parkin toward mitochondria to activate mitophagy . We now provide evidence that the mitophagy receptor pathway is also involved in mitophagy induced by the loss of the mitochondrial membrane potential. It is possible that the PGAM5/ FUNDC1 axis cooperates with the PINK1/Parkin pathway in mitophagy. Recently, PINK1 was found to interact with PGAM5, and loss of PGAM5 suppresses the mitochondrial degeneration caused by the inactivation of PINK1 (Imai et al., 2010; Sekine et al., 2012) . Additionally, proteomic analysis of Parkin substrates on mitochondria indicated that Parkin is able to ubiquitinate FUNDC1 (Sarraf et al., 2013) . Indeed, our studies demonstrate that knockdown of FUNDC1 reduced the Parkin translocation onto mitochondria (data not shown). It would be interesting to test whether PINK1 phosphorylates FUNDC1 and if the stabilization of PINK1 in response to the loss of the mitochondrial membrane potential required PGAM5/FUNDC1 for subsequent mitophagy. The results of the present study, together with our previous findings, provide further support for the notion that the PGAM5/FUNDC1 axis regulates hypoxiainduced mitophagy.
The question remains of what specific signal activates the PGAM5/FUNDC1 axis, leading to mitophagy. We observed that although both the loss of the mitochondrial membrane potential induced by the uncoupler-FCCP and hypoxia promoted the cleavage of PGAM5 (as shown Figure 4 ), likely via PARL (Sekine et al., 2012) , PGAM5 cleavage induced by hypoxia was not comparable to that induced by FCCP, and our data do not suggest its direct correlation with FUNDC1-dependent mitophagy. Previous studies have shown that Bcl-xL interacts with PGAM5 to regulate ASK activity associated with apoptosis (C) In vitro CK2 kinase assay. Immunoprecipitated CK2 subunits were incubated with GST-FUNDC1 or S13A mutant protein at 30 C for 30 min in kinase buffer. The reaction products were then subjected to western blotting using an anti-p-Ser13 antibody to analyze the ability of CK2 to phosphorylate FUNDC1. (D) CK2 catalytic subunits and its kinase-dead mutants (CK2a1K68M and CK2a2K69M) were immunoprecipitated by Flag antibody. In vitro CK2 kinase assay were performed as that in Figure 5C . Coomassie blue staining was used to visualize GST-FUNDC1 proteins. The phosphorylation level of FUNDC1 at Ser-13 was analyzed with an anti-p-Ser13 antibody. (E) In vitro CK2 kinase assay was performed with purified CK2 kinase and GST-FUNDC1, after which the reaction products were incubated with GST beads at 4 C for 2 hr. The beads were washed with lysis buffer for three times and with in vitro phosphatase assay buffer for another three times. In vitro phosphatase assay was performed with CK2-reacted GST-FUNDC1 and PGAM5 as described in Figure 3 . (F) Endogenous CK2 subunits were depleted from HeLa cell lysates through IP with the indicated antibodies. The CK2 subunit-depleted lysates were then incubated with GST-FUNDC1 or S13A mutant of the protein, as in (C) . Western blotting was subsequently performed to analyze the phosphorylation status of FUNDC1.
(G) An in vitro kinase assay using CK2 subunit-depleted lysates was performed as in (F) . The ratio of the band intensity of p-Ser13 to GST or a GST fusion protein was measured with ImageJ software. Data are the mean value of three experiments.
(H) HeLa cells were transfected with pLKO plasmids expressing shRNAs specifically targeting each CK2 subunit and then treated with puromycin to select stable CK2 subunit knockdown cell lines. The cells were finally harvested, and the cell lysates were subjected to western blotting. (legend continued on next page) (Lo and Hannink, 2006) . We recently found that FCCP and hypoxia could attenuate this interaction, leading to the release of PGAM5 from the complex of PGAM5 and Bcl-xL and, hence, the activation of mitophagy (our unpublished data). In addition, we found that these stresses promoted the association between PGAM5 and FUNDC1 but the dissociation of the CK2 and Src kinases from FUNDC1. This suggests a seesaw model of the interaction of FUNDC1 with PGAM5 and with the CK2 and Src kinases. Hypoxia triggers the translocation of CK2 catalytic subunits into the nuclei of cells (Pluemsampant et al., 2008) and thus decreases the possibility of CK2 phosphorylating FUNDC1 at the outer membrane of mitochondria. Recent report also showed that CK2 is able to phosphorylates ATG32, a mitophagy receptor in yeast, suggesting that CK2 may have a general role to regulate mitophagy both in mammalian systems and in yeast (Kanki et al., 2013) .
Several reports Hannink, 2006, 2008) showed that PGAM5 is localized at the outer membrane of mitochondria, while a recent paper (Sekine et al., 2012) suggested that PGAM5 may be localized at the inner membrane of mitochondria. PGAM5 was found to be highly resistant to proteinase-K digestion, and it is not completely digested by lower concentration of proteinase K even in the presence of Triton X-100 (Figure S6A) . A high concentration of protease-K (up to 500 mg/ml) is able to partially digest PGAM5, and it is completely digested in the presence of Triton X-100 ( Figure S6B ), indicating that PGAM5 may at least in part localize at the outer membrane of mitochondria. We also took the functional approach to address if PGAM5 is able to dephosphorylate FUNDC1 ( Figure S6C ). We incubated phosphorylated GST-FUNDC1 protein (which was phosphorylated at Ser-13 by addition of commercial CK2 kinase) with the mitochondria isolated from wild-type HeLa cells or PGAM5 knockdown cells. Intact mitochondria from HeLa cells are able to dephosphorylate GST-FUNDC1 at Ser-13, and it was significantly reduced when mitochondria were isolated from PGAM5 knockdown cells ( Figure S6C ). Our data suggest that the relatively small fraction of PGAM5 that exists in the outer membrane of mitochondria plays a major role in FUNDC1-dependent mitophagy
It was intriguing to find that an unphosphorylated FUNDC1 peptide encompassing both Ser-13 and LIR, including the 9th-25th amino acids, could potently block FCCP-induced mitophagy. This peptide is highly specific in blocking the interaction between FUNDC1 and LC3, without much effect on general autophagy (Figure 2 ). These data not only reinforce our notion of the specificity of this interaction and the importance of FUNDC1 phosphorylation status in relation to mitophagy, but also indicate that this study system is a tool for finding mimetic peptides to manipulate mitophagy. It is also conceivable that enhancement of mitophagy either through the activation of PGAM5 or inhibition of CK2 or Src kinase could be useful for preventing the accumulation of damaged mitochondria under disease conditions. Because dysregulation of mitophagy has been linked to neurodegenerative and other diseases, the results of the present study will be useful for understanding the molecular mechanisms involved in these diseases and offer multiple targets for therapeutic intervention.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection HeLa cells were cultured in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum (Hyclone) and 0.1 mg/ml penicillin-streptomycin at 37 C under 5% CO 2 . Hypoxic conditions were achieved in a hypoxia chamber (Billups-Rothenberg) flushed with a preanalyzed gas mixture of 1% O 2 , 5% CO 2 , and 94% N 2 .
Statistical Analysis
For quantitative analyses of cultured cells represented as histograms, values were obtained from three independent experiments and expressed as the mean ± SEM. Statistical analyses were performed using the Student's t test, with p values < 0.05 being considered significant. Significance levels of *p < 0.05 and **p < 0.01 versus the corresponding controls are indicated. All statistical data were calculated with GraphPad Prism software. 
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